Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy

Youqiong Ye, Qingsong Hu, Hu Chen, Ke Liang, Yuan Yuan, Yu Xiang, Hang Ruan, Zhao Zhang, Anren Song, Huiwen Zhang, Lingxiang Liu, Lixia Diao, Yanyan Lou, Bingying Zhou, Li Wang, Shengtao Zhou, Jianjun Gao, Eric Jonasch, Steven H. Lin, Yang XiaChunru Lin, Liuqing Yang, Gordon B. Mills, Han Liang, Leng Han

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Tumour hypoxia is a major contributor to resistance to anticancer therapies. Given that the results of hypoxia-targeted therapy trials have been disappointing, a more personalized approach may be needed. Here, we characterize multi-omic molecular features associated with tumour hypoxia and identify molecular alterations that correlate with both drug-resistant and drug-sensitive responses to anticancer drugs. Based on a well-established hypoxia gene expression signature, we classify about 10,000 tumour samples into hypoxia score-high and score-low groups across different cancer types from The Cancer Genome Atlas (TCGA) and demonstrate their prognostic associations. Then, we identify various types of molecular features associated with hypoxia status that correlate with drug resistance but, in some cases, also with drug sensitivity, contrasting the conventional view that hypoxia confers drug resistance. We further show that 110 out of 121 (90.9%) clinically actionable genes can be affected by hypoxia status and experimentally validate the predicted effects of hypoxia on the response to several drugs in cultured cells. Our study provides a comprehensive molecular-level understanding of tumour hypoxia and may have practical implications for clinical cancer therapy.

Original languageEnglish (US)
Pages (from-to)431-444
Number of pages14
JournalNature Metabolism
Volume1
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Pharmaceutical Preparations
Drug Resistance
Therapeutics
Neoplasms
Atlases
Hypoxia
Transcriptome
Cultured Cells
Genome
Genes
Tumor Hypoxia

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)
  • Internal Medicine
  • Cell Biology

Cite this

Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy. / Ye, Youqiong; Hu, Qingsong; Chen, Hu; Liang, Ke; Yuan, Yuan; Xiang, Yu; Ruan, Hang; Zhang, Zhao; Song, Anren; Zhang, Huiwen; Liu, Lingxiang; Diao, Lixia; Lou, Yanyan; Zhou, Bingying; Wang, Li; Zhou, Shengtao; Gao, Jianjun; Jonasch, Eric; Lin, Steven H.; Xia, Yang; Lin, Chunru; Yang, Liuqing; Mills, Gordon B.; Liang, Han; Han, Leng.

In: Nature Metabolism, Vol. 1, No. 4, 01.04.2019, p. 431-444.

Research output: Contribution to journalArticle

Ye, Y, Hu, Q, Chen, H, Liang, K, Yuan, Y, Xiang, Y, Ruan, H, Zhang, Z, Song, A, Zhang, H, Liu, L, Diao, L, Lou, Y, Zhou, B, Wang, L, Zhou, S, Gao, J, Jonasch, E, Lin, SH, Xia, Y, Lin, C, Yang, L, Mills, GB, Liang, H & Han, L 2019, 'Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy', Nature Metabolism, vol. 1, no. 4, pp. 431-444. https://doi.org/10.1038/s42255-019-0045-8
Ye, Youqiong ; Hu, Qingsong ; Chen, Hu ; Liang, Ke ; Yuan, Yuan ; Xiang, Yu ; Ruan, Hang ; Zhang, Zhao ; Song, Anren ; Zhang, Huiwen ; Liu, Lingxiang ; Diao, Lixia ; Lou, Yanyan ; Zhou, Bingying ; Wang, Li ; Zhou, Shengtao ; Gao, Jianjun ; Jonasch, Eric ; Lin, Steven H. ; Xia, Yang ; Lin, Chunru ; Yang, Liuqing ; Mills, Gordon B. ; Liang, Han ; Han, Leng. / Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy. In: Nature Metabolism. 2019 ; Vol. 1, No. 4. pp. 431-444.
@article{2735133ebcde48ad976c56d50a8a772f,
title = "Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy",
abstract = "Tumour hypoxia is a major contributor to resistance to anticancer therapies. Given that the results of hypoxia-targeted therapy trials have been disappointing, a more personalized approach may be needed. Here, we characterize multi-omic molecular features associated with tumour hypoxia and identify molecular alterations that correlate with both drug-resistant and drug-sensitive responses to anticancer drugs. Based on a well-established hypoxia gene expression signature, we classify about 10,000 tumour samples into hypoxia score-high and score-low groups across different cancer types from The Cancer Genome Atlas (TCGA) and demonstrate their prognostic associations. Then, we identify various types of molecular features associated with hypoxia status that correlate with drug resistance but, in some cases, also with drug sensitivity, contrasting the conventional view that hypoxia confers drug resistance. We further show that 110 out of 121 (90.9{\%}) clinically actionable genes can be affected by hypoxia status and experimentally validate the predicted effects of hypoxia on the response to several drugs in cultured cells. Our study provides a comprehensive molecular-level understanding of tumour hypoxia and may have practical implications for clinical cancer therapy.",
author = "Youqiong Ye and Qingsong Hu and Hu Chen and Ke Liang and Yuan Yuan and Yu Xiang and Hang Ruan and Zhao Zhang and Anren Song and Huiwen Zhang and Lingxiang Liu and Lixia Diao and Yanyan Lou and Bingying Zhou and Li Wang and Shengtao Zhou and Jianjun Gao and Eric Jonasch and Lin, {Steven H.} and Yang Xia and Chunru Lin and Liuqing Yang and Mills, {Gordon B.} and Han Liang and Leng Han",
year = "2019",
month = "4",
day = "1",
doi = "10.1038/s42255-019-0045-8",
language = "English (US)",
volume = "1",
pages = "431--444",
journal = "Nature Metabolism",
issn = "2522-5812",
number = "4",

}

TY - JOUR

T1 - Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy

AU - Ye, Youqiong

AU - Hu, Qingsong

AU - Chen, Hu

AU - Liang, Ke

AU - Yuan, Yuan

AU - Xiang, Yu

AU - Ruan, Hang

AU - Zhang, Zhao

AU - Song, Anren

AU - Zhang, Huiwen

AU - Liu, Lingxiang

AU - Diao, Lixia

AU - Lou, Yanyan

AU - Zhou, Bingying

AU - Wang, Li

AU - Zhou, Shengtao

AU - Gao, Jianjun

AU - Jonasch, Eric

AU - Lin, Steven H.

AU - Xia, Yang

AU - Lin, Chunru

AU - Yang, Liuqing

AU - Mills, Gordon B.

AU - Liang, Han

AU - Han, Leng

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Tumour hypoxia is a major contributor to resistance to anticancer therapies. Given that the results of hypoxia-targeted therapy trials have been disappointing, a more personalized approach may be needed. Here, we characterize multi-omic molecular features associated with tumour hypoxia and identify molecular alterations that correlate with both drug-resistant and drug-sensitive responses to anticancer drugs. Based on a well-established hypoxia gene expression signature, we classify about 10,000 tumour samples into hypoxia score-high and score-low groups across different cancer types from The Cancer Genome Atlas (TCGA) and demonstrate their prognostic associations. Then, we identify various types of molecular features associated with hypoxia status that correlate with drug resistance but, in some cases, also with drug sensitivity, contrasting the conventional view that hypoxia confers drug resistance. We further show that 110 out of 121 (90.9%) clinically actionable genes can be affected by hypoxia status and experimentally validate the predicted effects of hypoxia on the response to several drugs in cultured cells. Our study provides a comprehensive molecular-level understanding of tumour hypoxia and may have practical implications for clinical cancer therapy.

AB - Tumour hypoxia is a major contributor to resistance to anticancer therapies. Given that the results of hypoxia-targeted therapy trials have been disappointing, a more personalized approach may be needed. Here, we characterize multi-omic molecular features associated with tumour hypoxia and identify molecular alterations that correlate with both drug-resistant and drug-sensitive responses to anticancer drugs. Based on a well-established hypoxia gene expression signature, we classify about 10,000 tumour samples into hypoxia score-high and score-low groups across different cancer types from The Cancer Genome Atlas (TCGA) and demonstrate their prognostic associations. Then, we identify various types of molecular features associated with hypoxia status that correlate with drug resistance but, in some cases, also with drug sensitivity, contrasting the conventional view that hypoxia confers drug resistance. We further show that 110 out of 121 (90.9%) clinically actionable genes can be affected by hypoxia status and experimentally validate the predicted effects of hypoxia on the response to several drugs in cultured cells. Our study provides a comprehensive molecular-level understanding of tumour hypoxia and may have practical implications for clinical cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=85067971672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067971672&partnerID=8YFLogxK

U2 - 10.1038/s42255-019-0045-8

DO - 10.1038/s42255-019-0045-8

M3 - Article

AN - SCOPUS:85067971672

VL - 1

SP - 431

EP - 444

JO - Nature Metabolism

JF - Nature Metabolism

SN - 2522-5812

IS - 4

ER -